Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes Track

Preparation and imaging of arthritis of 99Tcm-DTPA-CB86 for TSPO targeted imaging

Xinhui Su, Peng Liu, Wentao Dong, Zhide Guo and Chao Ma
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 332;
Xinhui Su
3Department of Nuclear Medicine Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peng Liu
2Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wentao Dong
4Zhongshan Hospital Xiamen University, Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhide Guo
1Center for Molecular Imaging and Translational Med Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chao Ma
2Zhongshan Hospital Xiamen University Xiamen China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

332

Objectives: To prepare a novel radiolabeled TSPO ligand CB86 targeting agent 99Tcm-DTPA-CB86 and evaluate its biological properties.

Methods: DPTA-CB86 was prepared by coupling with a bifunctional chelating agent, and then labeled with 99Tcm to obtain 99Tcm-DTPA-CB86. The labeling efficiency, radiochemical purity, and stability were determined in vitro. In vitro cellular uptake and efflux were performed on RAW264.7 macrophage cells. Biodistribution and micro SPECT/CT imaging were investigated on Freund’s Adjuvant-Induced Left Arthritis in mice. SPSS 18.0 analysis software was used to conduct a t-test for the data that fit the normal distribution and homogeneity of variance. Results The labeling yields and radiochemical purity of 99Tcm-DTPA-CB86 were (95.86 ± 2.45) % and (97.45 ± 0.69) %, respectively. 99Tcm-DTPA-CB86 displayed good stability, which the radiochemical purity was more than > 90%, in PBS solution at 4 h. It also exhibited high specific TSPO binging in RAW264.7 macrophage cells in vitro. The highest uptake ratio was (36.45 ± 2.18) % at 3 h after incubation, and decreased significantly [(10.43 ± 2.01)%] after adding excessive unlabeled DTPA-CB86. The difference was significant (t = 6.217, P < 0.05) (Fig.1). The cell efflux study showed that 99Tcm-DTPA-CB86 has good cell retention by RAW264.7 cells, with only about 13.99 % (decreased from(33.31 ± 2.34)% to(19.32 ± 2.01)% of total input radioactivity) of 99Tcm-DTPA-CB86 efflux observed during 4.5 h to 8 h incubation (Fig.2). Biodistribution and MicroSPECT/CT imaging demonstrated uptake of 99Tcm-DTPA-CB86 in the left arthritic ankles was significantly increased compared with contralateral normal ankles (Fig.3). Uptake in the arthritic ankles could be largely blocked by an excess of DTPA-CB86 (Fig.4). Conclusion 99Tcm-DTPA-CB86 can be readily synthesized, clearly visualized arthritis and exhibited low background, suggesting its potential as a novel promising molecular probe targeting TSPO for arthritic SPECT imaging. [Key words] Translocator protein; Arthritis; Isotope labeling; Technetium radioisotope; Tomography, emission-computed, single-photon; Tomography, X-ray computed

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 59, Issue supplement 1
May 1, 2018
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation and imaging of arthritis of 99Tcm-DTPA-CB86 for TSPO targeted imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation and imaging of arthritis of 99Tcm-DTPA-CB86 for TSPO targeted imaging
Xinhui Su, Peng Liu, Wentao Dong, Zhide Guo, Chao Ma
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 332;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation and imaging of arthritis of 99Tcm-DTPA-CB86 for TSPO targeted imaging
Xinhui Su, Peng Liu, Wentao Dong, Zhide Guo, Chao Ma
Journal of Nuclear Medicine May 2018, 59 (supplement 1) 332;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes Track

  • Synthesis and preliminary biological evaluation of a novel P2X7R radioligand [18F]IUR-1601
  • In vivo evaluation of [225Ac]Ac-DOTAZOL for α-therapy of bone metastases
  • Case study: Evaluating the new University of Florida hybrid pediatric phantoms and tissue weighting factors from ICRP Publication 103 for diagnostic dosimetry
Show more Molecular Targeting Probes Track

Preclinical Probes for Cardiovascular, Endocrine & Other II

  • Nanoparticle PET imaging of NPRC receptor in brown adipose tissue
  • Synthesis and evaluation of N-18F-fluorodeoxyglycosyl aminohippuric as a novel PET renal agent
Show more Preclinical Probes for Cardiovascular, Endocrine & Other II

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire